ONIVYDE Trademark

Trademark Overview

On Wednesday, June 26, 2013, a trademark application was filed for ONIVYDE with the United States Patent and Trademark Office. The USPTO has given the ONIVYDE trademark a serial number of 85971097. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, May 18, 2022. This trademark is owned by Merrimack Pharmaceuticals, Inc.. The ONIVYDE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the diagnosis and treatment of cancer for human use
onivyde

General Information

Serial Number85971097
Word MarkONIVYDE
Filing DateWednesday, June 26, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, May 18, 2022
Registration Number4874816
Registration DateTuesday, December 22, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 27, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the diagnosis and treatment of cancer for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 9, 2013
Primary Code005
First Use Anywhere DateFriday, October 30, 2015
First Use In Commerce DateFriday, October 30, 2015

Trademark Owner History

Party NameIPSEN BIOPHARM LTD.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressWrexham LL139UF
GB
Party NameMerrimack Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameMerrimack Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameMerrimack Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Saturday, June 29, 2013NEW APPLICATION ENTERED
Tuesday, July 9, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 4, 2013ASSIGNED TO EXAMINER
Saturday, October 5, 2013NON-FINAL ACTION WRITTEN
Saturday, October 5, 2013NON-FINAL ACTION E-MAILED
Saturday, October 5, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 28, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 28, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 29, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 31, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 21, 2014ASSIGNED TO LIE
Monday, April 21, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 7, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 27, 2014PUBLISHED FOR OPPOSITION
Tuesday, May 27, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 22, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 12, 2015SOU TEAS EXTENSION RECEIVED
Monday, January 12, 2015SOU EXTENSION 1 FILED
Monday, January 12, 2015SOU EXTENSION 1 GRANTED
Wednesday, January 14, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 24, 2015SOU TEAS EXTENSION RECEIVED
Monday, July 20, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 24, 2015SOU EXTENSION 2 FILED
Monday, July 20, 2015SOU EXTENSION 2 GRANTED
Tuesday, July 21, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 4, 2015TEAS STATEMENT OF USE RECEIVED
Wednesday, November 4, 2015USE AMENDMENT FILED
Wednesday, November 18, 2015STATEMENT OF USE PROCESSING COMPLETE
Thursday, November 19, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, November 20, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 22, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, May 3, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 6, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 6, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 22, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, November 29, 2021TEAS SECTION 8 & 15 RECEIVED
Wednesday, May 18, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 18, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, May 18, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, December 22, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, December 18, 2025TEAS SECTION 8 & 9 RECEIVED

Related Keywords

onivyde cancer human treatment diagnosis preparations pharmaceutical